ストックスクリーナーアプリを入手
12.15
3.19%
-0.40
前日終値:
$12.55
開ける：
$12.56
24時間の取引高:
623.32K
Relative Volume:
0.82
時価総額：
$952.38M
収益：
$54.55M
当期純損益:
$-193.57M
株価収益率:
-4.2042
EPS:
-2.89
ネットキャッシュフロー:
$-181.86M
1週間 パフォーマンス:
-6.47%
1か月 パフォーマンス:
-19.00%
6か月 パフォーマンス:
-47.29%
1年 パフォーマンス:
-17.35%
1日の値動き範囲:
$12.00
$12.72
1週間の範囲:
$12.00
$13.57
52週間の値動き範囲:
$11.90
$29.56
Nurix Therapeutics Inc Stock (NRIX) Company Profile
名前
Nurix Therapeutics Inc
セクター
電話
(415) 660-5320
住所
1700 OWENS STREET, SUITE 205, SAN FRANCISCO
NRIX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NRIX
Nurix Therapeutics Inc
|
12.15 | 952.38M | 54.55M | -193.57M | -181.86M | -2.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
492.69 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
637.36 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
589.15 | 35.93B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
268.46 | 34.75B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
267.39 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Nurix Therapeutics Inc Stock (NRIX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-17 | 開始されました | Leerink Partners | Market Perform |
| 2024-12-10 | 開始されました | BTIG Research | Buy |
| 2024-12-06 | 開始されました | BMO Capital Markets | Outperform |
| 2024-10-24 | 開始されました | UBS | Buy |
| 2024-10-11 | 開始されました | Jefferies | Buy |
| 2024-09-06 | 再開されました | Robert W. Baird | Outperform |
| 2024-07-31 | 開始されました | Truist | Buy |
| 2023-06-26 | 再開されました | Oppenheimer | Outperform |
| 2023-03-09 | 開始されました | Barclays | Overweight |
| 2023-02-28 | 開始されました | Oppenheimer | Outperform |
| 2022-10-11 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-05-31 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2022-02-10 | 開始されました | Wells Fargo | Equal Weight |
| 2021-12-29 | 開始されました | H.C. Wainwright | Buy |
| 2021-10-14 | 開始されました | SVB Leerink | Outperform |
| 2021-06-04 | 再開されました | Robert W. Baird | Outperform |
| 2021-04-30 | 再開されました | Piper Sandler | Overweight |
| 2021-04-30 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-04-14 | 開始されました | Berenberg | Buy |
| 2020-11-19 | 開始されました | Robert W. Baird | Outperform |
| 2020-08-18 | 開始されました | JP Morgan | Overweight |
| 2020-08-18 | 開始されました | Needham | Buy |
| 2020-08-18 | 開始されました | Piper Sandler | Overweight |
| 2020-08-18 | 開始されました | Stifel | Buy |
すべてを表示
Nurix Therapeutics Inc (NRIX) 最新ニュース
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Receives $30.88 Consensus PT from Analysts - MarketBeat
Proficio Capital Partners LLC Acquires Shares of 19,952 Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Position Boosted by Charles Schwab Investment Management Inc. - MarketBeat
Nurix Therapeutics Announces Multiple Presentations at the American Association for Cancer Research (AACR) 2025 Annual Meeting - The Manila Times
Nurix Therapeutics Announces Multiple Presentations At The American Association For Cancer Research (AACR) 2025 Annual Meeting - Marketscreener.com
Nurix Therapeutics (NASDAQ:NRIX) Stock Price Down 6.2%Here's What Happened - MarketBeat
Q3 Earnings Estimate for NRIX Issued By Leerink Partnrs - MarketBeat
Nurix Therapeutics (NASDAQ:NRIX) Raised to "Hold" at Leerink Partnrs - MarketBeat
Victory Capital Management Inc. Buys 38,672 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Q1 Earnings Estimate for NRIX Issued By Leerink Partnrs - MarketBeat
Nurix Therapeutics (NASDAQ:NRIX) Stock Price Up 4.4%Should You Buy? - MarketBeat
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Shares May Have Slumped 25% But Getting In Cheap Is Still Unlikely - Simply Wall St
Nikko Asset Management Americas Inc. Acquires 236,620 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Nurix Therapeutics (NASDAQ:NRIX) Now Covered by Analysts at Leerink Partners - MarketBeat
Primecap Management Co. CA Has $4.37 Million Holdings in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Nurix Therapeutics (NASDAQ:NRIX) Upgraded at Leerink Partnrs - Defense World
Victory Capital Management Inc. Increases Stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - Defense World
Nurix Therapeutics (NASDAQ:NRIX) Shares Down 6.9%What's Next? - MarketBeat
Beyond The Numbers: 8 Analysts Discuss Nurix Therapeutics Stock - Benzinga
Nurix Therapeutics gets 'market perform' rating as Leerink starts coverage - TradingView
Leerink Partners Initiates Coverage of Nurix Therapeutics (NRIX) with Market Perform Recommendation - Nasdaq
Nurix Therapeutics' Bexobrutideg Gets Orphan Drug Designation For Waldenstrm Macroglobulinemia - Nasdaq
Nurix Therapeutics' Blood Cancer Drug Candidate Gets FDA Orphan Drug Designation - Marketscreener.com
Nurix Announces U.S. FDA Orphan Drug Designation Granted to Bexobrutideg (NX-5948) for the Treatment of Waldenström Macroglobulinemia - The Manila Times
Nurix Announces U.S. FDA Orphan Drug Designation Granted to Bexobrutideg (NX-5948) for the Treatment of - EIN News
Proficio Capital Partners LLC Takes Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Nurix Therapeutics grants stock options to new hires By Investing.com - Investing.com Australia
Nurix Therapeutics grants stock options to new hires - Investing.com India
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Nurix Therapeutics expands board with oncology veteran By Investing.com - Investing.com Australia
Nurix Therapeutics expands board with oncology veteran - Investing.com India
Nurix Therapeutics Appoints Drug Development Expert Roy D. Baynes, MB.Bch., M.Med., Ph.D., to Its Board of Directors - The Manila Times
Keytruda Developer Roy Baynes Strengthens Nurix Board in Strategic Move - StockTitan
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Sold by Candriam S.C.A. - MarketBeat
Insider Selling: Nurix Therapeutics, Inc. (NASDAQ:NRIX) CFO Sells 5,825 Shares of Stock - MarketBeat
Nurix Therapeutics Inc (NRIX) 財務データ
収益
当期純利益
現金流量
EPS
0.39%
0.34%
大文字化:
|
ボリューム (24 時間):